Impaired blood glucose levels in patients with dyslipidemia: What are the therapeutic implications? the PREVENDIAB study

  1. Esteban-Fernández, A.
  2. Bover-Freire, R.
  3. Guinea-López, R.
  4. Fácila, L.
Revue:
Future Cardiology

ISSN: 1744-8298,  1479-6678

Année de publication: 2019

Volumen: 15

Número: 3

Pages: 175-182

Type: Article

DOI: 10.2217/FCA-2018-0063 GOOGLE SCHOLAR
La source de données: Scopus